Weak Value Amplification-Based Biochip for Highly Sensitive Detection and Identification of Breast Cancer Exosomes

Biosensors (Basel). 2024 Apr 17;14(4):198. doi: 10.3390/bios14040198.

Abstract

Exosomes constitute an emerging biomarker for cancer diagnosis because they carry multiple proteins that reflect the origins of the parent cell. The highly sensitive detection of exosomes is a crucial prerequisite for the diagnosis of cancer. In this study, we report an exosome detection system based on quantum weak value amplification (WVA). The WVA detection system consists of a reflection detection light path and a Zr-ionized biochip. Zr-ionized biochips effectively capture exosomes through the specific interaction between zirconium dioxide and the phosphate groups on the lipid bilayer of exosomes. Aptamer-modified gold nanoparticles (Au NPs) are then used to specifically recognize proteins on exosomes to enhance the detection signal. The sensitivity and resolution of the detection system are 2944.07 nm/RIU and 1.22 × 10-5 RIU, respectively. The concentration of exosomes can be directly quantified by the WVA system, ranging from 105-107 particles/mL with the detection limit of 3 × 104 particles/mL. The use of Au NPs-EpCAM for the specific enhancement of breast cancer MDA-MB-231 exosomes is demonstrated. The results indicate that the WVA detection system can be a promising candidate for the detection of exosomes as tumor markers.

Keywords: biochip; breast cancer; exosomes; weak value amplification (WVA).

MeSH terms

  • Biomarkers, Tumor
  • Biosensing Techniques*
  • Breast Neoplasms* / diagnosis
  • Cell Line, Tumor
  • Exosomes*
  • Female
  • Gold* / chemistry
  • Humans
  • Limit of Detection
  • Metal Nanoparticles* / chemistry
  • Zirconium / chemistry

Substances

  • Gold
  • Biomarkers, Tumor
  • Zirconium